Picture of SK Biopharmaceuticals Co logo

326030 SK Biopharmaceuticals Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Sk Biopharmaceuticals Q2 Operating Loss 19 Billion Won, Up 52.7% From Year Earlier

SK Biopharmaceuticals Co Ltd  326030.KS :
    * SK BIOPHARMACEUTICALS: Q2 OPERATING LOSS 19 BILLION WON,
UP
52.7% FROM YEAR EARLIER

Source text for Eikon:  ID: 
Further company coverage:  326030.KS

Recent news on SK Biopharmaceuticals Co

See all news